PON1 and coronary artery disorder: PON1 activity in sera was decreased in all CAD patients compared to N subjects (SA, 35%, p = 0.0003; ACS, 48%, p = 4.8 × 10−7) and was significantly lower in ACS (20%, p = 0.04) compared to SA patients sera (Fig. 1b).